Nanoscopy technology can drive biological discovery not just with imagery, but also with meaningful quantitative data.

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

Researchers have developed a new organoid that mimics the human fetal pancreas, offering a clearer view of its early development.

Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

At GEN’s inaugural virtual summit on The State of AI in Drug Discovery, experts evaluated the evolution, opportunities, and ...

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis in humans. The ...

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.

Knowledge extraction: Through the application of AI and knowledge graphs, Wisecube were able to explore repurposed drugs for ...

SmartLabs’ new Custom Developed Solutions (CDS) platform provides specialized oversight and hands-on expertise in the design, ...